izpis_h1_title_alt

Effects of coenzyme Q$_{10}$ supplementation on oxidative stress markers, inflammatory markers, lymphocyte subpopulations, and clinical status in dogs with myxomatous mitral valve disease
ID Druzhaeva, Natalia (Author), ID Nemec Svete, Alenka (Author), ID Tavčar-Kalcher, Gabrijela (Author), ID Babič, Janja (Author), ID Ihan, Alojz (Author), ID Pohar, Katka (Author), ID Krapež, Uroš (Author), ID Domanjko-Petrič, Aleksandra (Author)

.pdfPDF - Presentation file, Download (367,55 KB)
MD5: CC92FD434DADF93F2ED55C1E25C6F151
URLURL - Source URL, Visit https://www.mdpi.com/2076-3921/11/8/1427 This link opens in a new window

Abstract
Scarce data exist on the effects of coenzyme Q$_{10}$ (CoQ$_{10}$) supplementation in dogs with myxomatous mitral valve disease (MMVD). The purpose of this study was to investigate the effect of CoQ$_{10}$ supplementation on oxidative stress markers (glutathione peroxidase, F2-isoprostanes), markers of inflammation (tumor necrosis factor-α, TNF soluble receptor II, leucocytes, and their subtypes), lymphocyte subpopulations (T helper and cytotoxic T lymphocytes, including activated T lymphocytes, and B lymphocytes), and echocardiographic and clinical parameters in dogs with MMVD. In this randomized, controlled, double-blind, longitudinal study, 43 MMVD dogs in stages ACVIM (American College of Veterinary Internal Medicine classification) B2 and ACVIM C and D (congestive heart failure (CHF)) received water-soluble coenzyme Q$_{10}$ (100 mg twice daily) or placebo for 3 months, and 12 non-supplemented healthy dogs served as controls. All parameters were measured before and after supplementation in MMVD dogs and once in healthy dogs. CoQ$_{10}$ supplementation had a positive impact on neutrophil percentage, lymphocyte percentage, and lymphocyte concentration in our cohort of dogs with CHF (ACVIM C and D). Conclusion: CoQ$_{10}$ as an oral supplement may have benefits in terms of decreasing inflammation in dogs with MMVD and CHF.

Language:English
Keywords:coenzyme Q$_{10}$, ubiquinone, supplementation, myxomatous mitral valve disease, congestive heart failure, dog, oxidative stress, inflammation, lymphocytes, neutrophils, coenzymes, heart failure
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:VF - Veterinary Faculty
MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2022
Number of pages:22 str.
Numbering:Vol. 11, iss. 8, art. 1427
PID:20.500.12556/RUL-138596 This link opens in a new window
UDC:636.7.09:577:616
ISSN on article:2076-3921
DOI:10.3390/antiox11081427 This link opens in a new window
COBISS.SI-ID:116770819 This link opens in a new window
Publication date in RUL:02.08.2022
Views:452
Downloads:115
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Antioxidants
Shortened title:Antioxidants
Publisher:MDPI
ISSN:2076-3921
COBISS.SI-ID:522976025 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Projects

Funder:ARRS - Slovenian Research Agency
Project number:P4-0053
Name:Endokrini, imunski in encimski odzivi pri zdravih in bolnih živalih

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back